U.S. Social Prescribing Leadership Survey and Evidence Synthesis

A 2025 national survey of social prescribing movement leaders identifies key barriers and opportunities for integrating non-clinical community supports into U.S. healthcare. The document synthesizes epidemiologic, economic, and implementation evidence for social prescribing as a strategy to address aging, mental illness, and social isolation. Authored by Alan Siegel and released under CC-BY-4.0 in June 2026, this 1.9 MB text file analyzes challenges like fragmented referral pathways and measurement deficits.

Use Cases

• Analyzing barriers to social prescribing adoption based on survey insights from movement leaders
• Modeling the potential impact of social connection on healthcare burden using synthesized economic evidence
• Designing implementation frameworks for value-based care based on identified policy and financing challenges

Strengths

• Includes data from a national survey of social prescribing leaders conducted ahead of a 2025 summit
• Synthesizes evidence from over 30 countries where social prescribing has been developed
• Released under a permissive CC-BY-4.0 license for broad reuse

Limitations

• The primary data format is a DOCX document, which may require parsing to extract structured insights
• Row count and column-level documentation are absent, limiting suitability assessment for quantitative analysis
• The dataset's 1.9 MB size suggests it is a text document rather than a large-scale data collection

Provenance

Source

Alan Siegel

Collection Method

Synthesis of epidemiologic, economic, and implementation evidence, plus a national survey of movement leaders.

Time Range

Survey conducted ahead of the 2025 U.S. Social Prescribing Leadership Summit.

Freshness

Last updated 2026-06-04 05:42:54

Geography

United States, with reference to over 30 other countries.